Alnylam Pharmaceuticals | ALNY - 净收入

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	净收入	更改		日
Acadia Pharmaceuticals	USD 273.57M		201.79M	2025-12
Agios Pharmaceuticals	USD -108.04M		4.61M	2025-12
Alnylam Pharmaceuticals	USD 186.42M		64.66M	2025-12
Amgen	USD 1.33B		1.88B	2025-12
Arrowhead Research	USD 30.81M		54.56M	2025-12
BioCryst Pharmaceuticals	USD 245.84M		232.95M	2025-12
BioMarin Pharmaceutical	USD -46.57M		15.83M	2025-12
Incyte	USD 299.28M		124.89M	2025-12
Ionis Pharmaceuticals	USD -229M		100.39M	2025-12
Moderna	USD -200M		625M	2025-09
Neurocrine Biosciences	USD 209.5M		102M	2025-09
Novartis	USD 2.41B		1.52B	2025-12
PTC Therapeutics	USD -134.96M		150.86M	2025-12
Regeneron Pharmaceuticals	USD 844.6M		615.4M	2025-12
Sangamo BioSciences	USD -36.13M		12.96M	2024-06
Sanofi	EUR -801M		3.6B	2025-12
Sarepta Therapeutics	USD -412.23M		232.28M	2025-12
Takeda	JPY 103.64B		115.44B	2025-12
Tectonic Therapeutic	USD -19.23M		186K	2025-12
Ultragenyx Pharmaceutical	USD -129M		51.41M	2025-12
Vertex Pharmaceuticals	USD 1.19B		108.2M	2025-12
Xencor	USD -6.65M		626K	2025-12